Why the study?
The study was conducted to analyze the single and combined effects of medication adherence and compliance with lifestyle recommendations on cardiovascular events and mortality in patients with type 2 diabetes and advanced stages of atherosclerosis.
Does persistent medication adherence and compliance with lifestyle recommendations reduce MACE and one-year mortality in patients with type 2 diabetes and advanced atherosclerosis?
Does persistent medication adherence and compliance with lifestyle recommendations reduce MACE and one-year mortality in patients with type 2 diabetes and advanced atherosclerosis?
Persistent adherence to both prescribed medications and lifestyle recommendations has an additive effect in reducing MACE and one-year mortality in high-risk patients with type 2 diabetes and advanced atherosclerosis.
Answers are grounded in this paper and cite their sources.
May support dual adherence emphasis in high-risk T2D; hypothesis-generating, requiring RCTs before practice change.
This study analyzed the single and combined effects of medication adherence and compliance with lifestyle recommendations on cardiovascular events and mortality in patients with type 2 diabetes and advances stages of atherosclerosis over a period of one year.Evaluation of medication adherence included antidiabetics, statins, dual antiplatelets and ACEI/ARBs, whereas lifestyle recommendations included healthy nutrition, physical activity and smoking cessation.Persistent medication adherence and lifestyle changes have shown to be equally effective to reduce the incidence of MACE and one-year mortality in patients representing a population with highly advanced stages of atherosclerotic disease, and positive effects added up to a double effect if patients were persistently adherent and compliant with both interventions.
No takes yet. Share an insight, caveat, or question.
Shalaeva et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: